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Earlier, we detected pIX of BAdV-3 as a 14-kDa protein in purified virions. Analysis of BAdV-3 pIX using different region antibodies
revealed that the N-terminus and central domain of the pIX contain immunogenic sites and are not exposed on the surface of BAdV-3 virion. This
suggested that the C-terminus of BAdV-3 pIX (125 amino acid) may be exposed on the virion and may be used as a site for incorporation of
heterologous peptides or proteins.We constructed recombinant BAV950 containing a small peptide (21 amino acid), including the RGDmotif or
recombinant BAV951 containing enhanced yellow-green fluorescent protein (EYFP) fused to the C-terminus of pIX. Western blot analysis
demonstrated that the chimeric pIX-RGD was incorporated into virion capsids. Incorporation of the RGD motif into the pIX resulted in
significant augmentation of BAdV-3 fiber knob-independent infection of the integrin-positive cells, suggesting that RGD motifs are displayed
on the surface of virion capsids and are accessible for binding to integrins. Analysis of BAV951 revealed that the chimeric pIX is incorporated
into virion capsids and EYFP containing the C-terminus of pIX is exposed on the surface of the virion.Moreover, insertion of chimeric pIXs was
maintained without change through successive rounds of viral replication. These results suggested that in contrast to major capsid proteins
(hexon, penton, fiber), the minor capsid protein IX can be use for the incorporation of targeting ligands based on either small peptides or longer
polypeptides.
D 2004 Elsevier Inc. All rights reserved.Keywords: BAdV-3; pIX; RGD; EYFP; TropismThe Adenoviridae family currently includes at least 70
serotypes of animal adenoviruses and 51 serotypes of human
adenoviruses (HAdV) (Mei et al., 2003). Adenoviruses can
infect a great variety of post-mitotic cells, even those asso-
ciated with highly differentiated tissues. The adenovirus
capsid consists of three major structural proteins, hexon
(II), penton base (III), and knobbed fiber (IV), along with
many other minor structural proteins, namely VI, VIII, IX,
and IIIa (Stewart, 2002). Although the complex process of
entry and intracellular transit involves several structural
proteins, it appears that the penton base and the fiber proteins
are responsible for the early steps of virus entry pathway.
Initially, the C-terminal knob domain of the fiber protein
binds with the primary cellular receptor (Louis et al.,0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2003.12.007
$ Published as VIDO Journal article # 358.
* Corresponding author. Vaccine and Infectious Disease Organization
(VIDO), University of Saskatchewan, 120 Veterinary Road, Saskatoon, SK,
Canada S7N 5E3. Fax: +1-306-966-7482.
E-mail address: Tikoo@Sask.Usask.ca (S.K. Tikoo).1994;Wickham et al., 1993). A fiber receptor for majority
of HAdVs has been identified as the coxsackie/adenovirus
receptor (CAR) (Bergelson et al., 1997; Roelvink et al., 1998;
Tomko et al., 1997). Following binding to the fiber receptor,
the RGD motif within the penton base interacts with aVh
integrins and facilitates virus internalization via receptor-
mediated endocytosis (Greber et al., 1993; Mathias et al.,
1994;Wickham et al., 1993). As the RGDmotif is not present
in the fiber or the penton base protein of wild-type BAdV-3,
the integrin-positive cells are not efficiently transduced by the
virus (Wu and Tikoo, 2004).
To provide the therapeutic effect where needed, the
adenovirus vector should be capable of delivering genes to
specific cells. Because the pattern of viral receptor expression
varies among different tissues (Fechner et al., 1999), the
natural tropism of the adenovirus needs to be changed.
Genetic engineering of HAdV capsid proteins to incorporate
targeting ligands has been used to modify the tropism of
HAdV vectors (Wickham, 2000). Several peptide ligands
have been inserted in major capsid proteins, namely fiber
A. Zakhartchouk et al. / Virology 320 (2004) 291–300292(Belousova et al., 2002; Dmitriev et al., 1998; Mizuguchi et
al., 2001; Wickham et al., 1996b, 1997; Xia et al., 2000),
hexon (Vigne et al., 1999), or penton (Wickham et al., 1996a)
of HAdV. However, the structure of capsid proteins has
hampered the effectiveness of this approach by limiting the
tolerance of capsid proteins towards insertion of longer
peptides. Thus, this targeting approach may not be useful
for many candidate receptors.
Protein pIX is a minor structural component of the virion,
which acts as a capsid cement thus enhancing the thermal
stability of the virion (Colby and Shenk, 1981). It influences
the transcriptional activity of viral promoters (Rosa-Cala-
trava et al., 2001) and is essential for the packaging of full-
length viral DNA (Ghosh-Choudhury et al., 1987). Earlier
studies indicated that C-terminal region of pIX is located on
the surface of the capsid (Akalu et al., 1999; Dmitriev et al.,
2002), suggesting that it could be used for insertion of
targeting ligands. Recently, the minor capsid protein pIX
of HAdV-5 has also been used for insertion of small
heterologous peptide sequences (Dmitriev et al., 2002).
The pIX protein of BAdV-3 is 125 amino acids long and
shows homology of 16–28% to the pIX proteins of other
adenoviruses (Reddy et al., 1998). Unlike HAdV (Berk andFig. 1. Western blot analysis of pIX in wild-type BAdV-3-infected cells. Proteins fr
cells (lane 2), or purified BAdV-3 virions (lane 3) were separated by 12.5% SDS-PA
The separated proteins were probed in Western blots by anti-pIX M1 (A) or N1 (B)
particles by immunogold electron microscopy using N1 (C) or M1 (D).Sharp, 1978), the BAdV-3 pIX transcript is 3V co-terminal
with E1A and E1B transcripts. The pIX of BAdV-3 is
detected as a 14-kDa protein in virus-infected cells and is
the component of virion capsid (Reddy et al., 1999a). To
assess the feasibility of incorporating heterologous sequen-
ces into BAdV-3 pIX, we constructed and characterized
recombinant BAdV-3 encoding the chimeric pIX containing
either the RGD motif or the enhanced yellow-green fluo-
rescent protein (EYFP) fused to the C-terminus of the
protein.Results
Characterization of BAdV-3 pIX
To characterize the pIX protein in detail, protein-specific
antisera were raised by immunizing rabbits with synthetic
peptides coupled to a carrier. To determine if antisera raised
against the pIX peptide recognize the protein, Western blot
analysis was performed. As expected, M1 antisera (aa 61–
80) recognized a protein of 14 kDa in BAdV-3-infected cells
(Fig. 1A, lane 2) and purified virions (Fig. 1A, lane 3). Noom mock-infected MDBK cells (lane 1), wild-type BAdV-3-infected MDBK
GE under reducing conditions and transferred to nitrocellulose membranes.
sera. (C and D) Localization of pIX on capsid surfaces of wild-type BAdV-3
A. Zakhartchouk et al. / Virolosuch band could be observed in mock-infected cells (Fig.
1A, lane 1). Similarly, N1 antisera (aa 13–32) recognized a
protein of 14 kDa in BAdV-3-infected cells (Fig. 1B, lane 2)
and purified virions (Fig. 1B, lane 3), but not in mock-
infected cells (Fig. 1B, lane 1). However, no such band
could be detected in BAdV-3-infected cells or purified
virions using either C1 (aa 80–99) or C2 (aa 90–110)
antisera.
To determine the antigenic regions of pIX exposed on
the virus particle, immune electron microscopy was per-
formed using purified virions and pIX-specific antisera. As
seen in Fig. 1, partially disrupted capsids of virions were
labeled with N1 (Fig. 1C) and M1 (Fig. 1D) sera.
However, no labeling was detected when N1 or M1 sera
were incubated with complete BAdV-3. These results
suggested that antigenic sites in the N terminus (amino
acid 13–32 and 61–80) of pIX are not exposed in the
virion.
Analysis of BAdV-3 pIX sequence
Although the protein sequence identities between BAdV-3
pIX and other adenoviruses are not high (Reddy et al., 1998),
we could clearly identify two sequences common in pIX of all
known adenoviruses (Fig. 2A). One of them is the conserved
element that can be located at the N-terminus of the protein.
In HAdV-2 and -5, this sequence is necessary for pIX incor-
poration into the capsid (Rosa-Calatrava et al., 2001). An-
other sequence is a putative leucine-zipper, comprising four
leucine and one valine residues, each spaced six residues
apart. Studies on HAdV revealed the requirement of this
sequence for transactivation of the promoters (Lutz et al.,
1997) and formation of nuclear inclusions (Rosa-Calatrava et
al., 2001).Fig. 2. Amino acid sequences of pIX. (A) Wild-type BAdV-3 pIX. The conserved
chimeric pIX. RGD-containing peptide sequence is underlined. (C) BAV951 chimConstruction of pIX-modified BAdV-3
Because the N-terminal domain appears to be embedded
in virion capsid, we choose to incorporate heterologous
peptide or protein into the C-terminus of BAdV-3 pIX. We
used the HpaI site (nt 3560 of BAdV-3 genome) in the 3Vend
of the pIX gene to incorporate heterologous sequences into
the BAdV-3 pIX C-terminus. This resulted in the removal of
the last four amino acids of the wild-type BAdV-3 pIX. The
plasmids used for constructing chimeric pIX are depicted in
Fig. 3. The genes encoding pIX-RGD and pIX-EYFP were
inserted individually into the BAdV-3 genome using the
homologous recombination machinery of Escherichia coli
(Chartier et al., 1996). The PacI-digested pFBAV950,
pFBAV951, or pFBAV3 plasmid DNAs were transfected
into VIDO R2 cells (HAdV-5 E3-transformed fetal bovine
retina cells; Reddy et al., 1999b) and produced cytopathic
effects in 14 days. The infected cell monolayers showing
50% cytopathic effects were collected, freeze–thawed, and
recombinant viruses were plaque purified and propagated in
Madin Darby bovine kidney (MDBK) cells. The recombi-
nant BAdV-3s were named BAV950 (pIX-RGD) and
BAV951 (pIX-EYFP). The amino acid sequence of the
modified pIX in BAV950 is presented in Fig. 2B. The last
four amino acids on the C-terminus of pIX were replaced
with the 21 amino acid sequence containing the RGD motif
and a short spacer with the GS repeats. Amino acid sequence
of modified pIX in BAV951 is presented in Fig. 2C. The last
four amino acids in the C-terminus of pIX were replaced
with the 242 amino acid of EYFP. The viral DNA was
extracted and analyzed by PCR using primers P91, 5V-
CTAATCGATACATGTAC ACTG-3V (nt 3057–3077); and
P92, 5V-CCAACCGGTTGTGGAAAATC-3V(nt 4450 –
4469). As expected, a 1393-bp PCR fragment could be
gy 320 (2004) 291–300 293sequence element and putative leucine zipper are underlined. (B) BAV950
eric pIX. The EYFP sequence is underlined.
,Fig. 3. Schematic diagram of the plasmids. The map of the plasmids depicting the location of different genes and restriction enzyme sites is shown. The m is not drawn to the scale. The restriction enzyme sites
(HpaI in pBAVNdA and, BsaBI and PmeI in pFBAV3) are shown in bold.
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A. Zakhartchouk et al. / Virology 320 (2004) 291–300 295detected in wild-type BAdV-3 DNA (Fig. 4A, lane 1). As a
result of the insertion of heterologous sequences, PCR
fragments of 1456 and 2125 bp could be detected in passage
1 of BAV950 (Fig. 4A, lane 2) and passage 1 of BAV951
(Fig. 4A, lane 4) DNAs, respectively. Similar PCR fragments
could also be detected in passage 10 DNA of BAV950 (Fig.
4A, lane 3) or BAV951 (Fig. 4A, lane 5).
Incorporation of modified pIX into BAdV-3 capsid
The wild-type BAdV-3, BAV950, and BAV951 were
purified by CsCl gradient centrifugation. The virion proteins
denatured by boiling in sodium-dodecyl sulphate (SDS) and
2-mercaptoethanol were separated by SDS-polyacrylamide
gel electrophoresis (PAGE) and analyzed by Western blot-
ting using anti-pIX M1 sera (Reddy et al., 1999a). As
expected, anti-pIX M1 sera recognized a protein of 14 kDa
in wild-type BAdV-3 (Fig. 4B, lanes 1 and 3). In contrast,
anti-pIX M1 sera recognized a protein of 16 kDa in
BAdV950 (Fig. 4B, lane 2). The increase in the molecular
mass of pIX in BAV950 is consistent with the addition of 17
extra amino acids, thus confirming the presence of RGD
sequences in pIX of BAV950 capsids.Fig. 4. Analysis of recombinant BAdV-3s. (A) PCR products were amplified usin
(lane 1)-, BAV950 (lanes 2 and 3)-, or BAV951 (lanes 4 and 5)-infected MDBK ce
(lane 4) and passage 10 (lane 5). 1-kb+ molecular weight markers (lane M). The
CsCl-purified wild-type BAdV-3 (lanes 1 and 3), BAV950 (lane 2), or BAV951 (la
12% SDS-PAGE under reducing conditions. Electrophoretically resolved viral pr
anti-pIX M1 sera (lanes 1, 2, 3, and 4) or anti-EYFP sera (lanes 5 and 6). The mol
on the capsid surface of wild-type BAdV-3 or BAV951 particles by immunogold
BAV951 under fluorescent microscope.The anti-pIX M1 sera recognized a protein of 41 kDa in
CsCl-purified BAV951 (Fig. 4B, lane 4). A protein of similar
molecular weight could also be detected in CsCl-purified
BAV951 (Fig. 4B, lane 6), but not in wild-type BAdV-3 (Fig.
4B, lane 5), using anti-EYFP sera. These results confirmed
the presence of EYFP in pIX of BAV951 capsids. To
determine if EYFP incorporated into modified pIX is dis-
played on the surface of BAV951 particles, immunoelectron
microscopy was performed using CsCl-purified BAV951vi-
rions and anti-EYFP sera. As can be seen in Fig. 4C, the
BAV951 virions were labeled with EYFP-specific antibodies
and gold-tagged protein A, whereas the BAdV-3 virions did
not react with the anti-EYFP sera. In addition, CsCl-purified
BAV951 showed green fluorescence when visualized under
fluorescent microscope (Fig. 4D).
Infection efficiency of pIX-modified BAdV-3
To determine whether the incorporation of RGD in
modified pIX is displayed on the surface of the BAV950
virion, we evaluated the infection efficiency of BAV950 of
integrin-containing cells (HeLa and A549). The cells were
infected with BAdV-3 or BAV950 at a multiplicity ofg primers (P91, P92) and the viral DNAs isolated from wild-type BAdV-3
lls. BAV950 passage 1 (lane 2) and passage 10 (lane 3), BAV951 passage 1
size of molecular weights is shown to the left of the panel. (B) Samples of
nes 4 and 6) were boiled in Laemmli loading sample buffer and separated by
oteins were transferred to the nitrocellulose and probed in Western blot by
ecular weight of observed proteins is shown. (C) Localization of pIX-EYFP
electron microscopy using anti-EYFP. (D) Visualization of CsCl-purified
Fig. 5. Quantitation of viral genomes. Total DNAwas extracted from virus-
infected cells 48 h postinfection. The number of viral genomes present in
A459 andHeLa cells was estimated by real-time PCR as described in the text.
A. Zakhartchouk et al. / Virology 320 (2004) 291–300296infection of 10 TCID50/cell (one TCID50 is defined as the
highest dilution of the virus showing cytopathic effects in
50% of the replicates). After 2 h of adsorption, the cells wereFig. 6. Accessibility of pIX-incorporated RGD ligand for binding. (A) Monolayers
knob protein or MEM for 10 min. Wild-type BAdV-3 or BAV950 was then adde
Monolayers of A549 cells in 12-well plates were incubated with RGD containing
BAdV-3 or BAV950 was then added at a multiplicity of infection of 10 for 30 min
media containing 0.7% agarose. After 3 days of incubation at 37 jC, the agarose o
were stained with anti-DBP and infectious units of BAdV-3 were counted as descr
triplicate determinations.washed twice with PBS and media were changed. At 48
h post infection, the cells were trypsinized and harvested.
Total DNA was extracted from the cells and DNA aliquots
were subjected to real-time PCR analysis. As seen in Fig. 5,
compared to BAdV-3, we found 10-fold more viral DNA in
BAV950-infected A549 or HeLa cell lines.
To determine if this increased infection of integrin-posi-
tive cells was due to the RGD motif in modified pIX of
BAV950, integrin-positive human A459 cells in 12-well
plate (2  105 cells/well) were incubated with wild-type
BAdV-3 or BAV950 at a multiplicity of infection of 10
TCID50/cell in serum-free media. After 30 min of incubation,
the media were aspirated and cell monolayer was overlaid
with minimum essential medium (MEM) containing 5% fetal
bovine serum (FBS) and 0.7% agarose. After 3 days of
incubation at 37 jC, the agarose overlay was removed and
the cells were fixed with 100% methanol. The cells were
stained with anti-BAdV-3 DBP antibodies and infectious
units of BAdV-3 were counted as described earlier (Zhou et
al., 2001). As seen in Fig. 6A, compared to the wild-type
BAdV-3, 3.5-fold more infectious units of the BAV950 virusof A549 cells in 12-well plates were incubated with purified BAdV-3 fiber
d at a multiplicity of infection of 10 for 30 min at room temperature. (B)
peptide (QAGTFALRGDNPQG) or MEM for 10 min at 4 jC. Wild-type
at 4 jC. Finally, the viruses were aspirated and the cells were overlaid with
verlay was removed and the cells were fixed with 100% methanol. The cells
ibed (Zhou et al., 2001). Each bar represents the cumulative mean F SD of
Fig. 7. Viral titer of recombinant and wild-type BAdV-3. Near confluent
monolayers of MDBK cells were infected with recombinant or wild-type
BAdV-3. At 72 h postinfection, the cells and culture media were harvested,
freeze– thawed, and the viruses were titrated on MDBK cells as described in
the text.
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infection efficiency was due to binding of BAV950 to the
integrins, we infected A549 cells in the presence of soluble
BAdV-3 fiber knob protein (70 Ag/ml). As seen in Fig. 6A,
the presence of BAdV-3 fiber knob protein caused 90%
reduction in the detection of BAdV-3 infectious units in
A549 cells. However, there was 18% reduction in the
detection of BAV950 infectious units in A549 cells (Fig.
6A). To confirm that the increased binding of BAV950 was
due to the RGDmotif, we infected A549 cells in the presence
of RGD containing peptide (QAGTFALRGDNPQG). The
presence of RGD peptide caused 68% reduction in the
detection of BAV950 infectious units in A549 (Fig. 6B).
However, there was no significant difference in the detection
of BAdV-3 infectious units in A549 (Fig. 6B).
Viral growth
To estimate virus yield, MDBK cells in 12-well plate (2
105 cells per well) were infected with BAdV-3, BAV950, or
BAV951 at a multiplicity of infection of 1 TCID50/cell. At 72
hpi, cells and culture media were harvested, freeze–thawed,
and virus infectious titer was determined by limiting dilution
method inMDBK cells. As seen in Fig. 7, the titer of BAV950
and BAV951 was lower (1.5–2 logs) compared to wild-type
BAdV-3.Discussion
Recombinant HAdVs from subgroup C have proved to be
highly efficient in transducing foreign genes to a variety of
cells and tissues. However, this promiscuous tropism of
HAdV vectors results in uncontrolled gene transfer to both
target and nontarget cells, thus compromising the efficacy of
gene delivery (Wickham, 2000). In addition, certain cell
types are not efficiently infected with HAdV vectors. Toovercome these limitations, mutagenesis (to alter native
tropism) and genetic modification (insertion of peptide
ligands) of major capsid proteins (fiber, hexon, and penton)
have been employed to redirect the HAdV vector to a cell of
interest (Dmitriev et al., 1998; Mizuguchi et al., 2001; Vigne
et al., 1999; Wickham et al., 1996a, 1996b, 1997; Xia et al.,
2000). However, structural properties of major capsid pro-
teins have put constraints on the length of the inserted
peptide ligand (Dmitriev et al., 1998; Wickham, 2000;Wick-
ham et al., 1997). An alternate to this strategy may be the
modification of minor capsid proteins (Dmitriev et al., 2002).
Here, we report the (a) construction and characterization of
recombinant BAdV-3 expressing chimeric pIX, (b) stable
incorporation of chimeric pIX (pIX-RGD) into mature
BAdV-3 virions resulting in increase of BAdV-3 infection
efficiency of integrin-positive human A549 and HeLa cells,
and (c) stable incorporation of modified pIX containing
heterologous polypeptide (EYFP) into virions.
Earlier, we have demonstrated that the pIX of BAdV-3 is
detected as a 14-kDa protein in virus-infected cells and is the
component of virion capsid (Reddy et al., 1999a). Analysis
of BAdV-3 pIX using antibodies produced against different
regions suggested that the N-terminus (amino acid 13–32)
and central domain (amino acid 61–80) of pIX contain
immunogenic sites. However, it is possible that the C-
terminus may contain immunogenic sites that were not
present in overlapping synthetic peptides. While immuno-
genic sites of HAdV-3 pIX are both in the N- and the C-
terminus of the protein, the immunogenic sites of HAdV-2
pIX appear to be located primarily in the N-terminus of the
protein (Akalu et al., 1999).
Despite differences in the accessibility of antigenic deter-
minants of pIX in intact HAdV virions, it appears that the
topography of pIX is identical in icosahedral capsids of
different adenoviruses (Akalu et al., 1999; Dmitriev et al.,
1998). While the C-terminal domain of pIX is located on the
surface of the virion, the N-terminal domain is hidden inside
the virion (Akalu et al., 1999; Dmitriev et al., 2002).
Immunogold electron microscopy of CsCl-purified BAdV-
3 virions using pIX-specific sera indicated that antigenic
regions in the N-terminus (amino acid 13–32 and 61–80) of
pIX are not exposed in the virion. This suggested that like
other adenoviruses, the C-terminus of pIX may be exposed
on the surface of the BAdV-3 capsid.
To confirm the orientation of pIX and to determine if it
can be used for the incorporation of heterologous peptide,
we isolated recombinant BAV950 encoding modified pIX
(containing 21 amino acid peptides including the RGD
motif fused to the C-terminus of pIX). Western blot analysis
demonstrated that the chimeric pIX is stably expressed in
BAV950-infected cells and is incorporated into viral cap-
sids. As the RGD motif is not present in the fiber or the
penton base protein of wild-type BAdV-3, the integrin-
positive cells are not efficiently transduced by the virus
(Wu and Tikoo, 2004). However, BAV950 transduced
integrin-positive cells more efficiently than wild-type
A. Zakhartchouk et al. / Virology 320 (2004) 291–300298BAdV-3. This increased transduction of integrin-positive
cells was not affected by inhibiting fiber knob-dependent
virus cell interaction using purified BAdV-3 fiber knob
protein. However, increased transduction of integrin-posi-
tive cells was inhibited in the presence of RGD peptide.
These results suggest that the RGD motifs in chimeric pIX
are exposed on the surface of BAV950 virions and are
accessible for interaction with integrins present on the
surface of cells.
Although major capsid proteins have been used for
insertion of peptide ligands, the structural properties of
these proteins have put limitations on the insertion of
longer peptides or polypeptide ligands. To determine if
pIX can be used for the incorporation of a heterologous
polypeptide, we constructed BAV951 encoding chimeric
pIX-EYFP (EYFP fused to C-terminus of pIX). Western
blot analysis demonstrated that the chimeric pIX is stably
expressed in BAV951-infected cells and is incorporated
into viral capsids. In addition, immunogold electron mi-
croscopy revealed that EYFP was exposed on the surface of
BAV951 virions. Moreover, the genome of BAV951
appeared to be stable after several passages. These results
suggest that genetic modification of adenovirus pIX incor-
porating high-affinity polypeptide ligands including single
chain antibodies could be possible without affecting viral
assembly.
A number of features of BAdV-3 including the absence
of preexisting antibodies in humans and resistance to
neutralization by human sera containing HAdV-5 neutraliz-
ing antibodies (Wu and Tikoo, manuscript in preparation)
make it attractive for use as a vector in human vaccination.
However, BAdV-3 transduces nonbovine cells including
human cells poorly (Wu and Tikoo, 2004). As such,
attempts have been made to alter the tropism of BAdV-3
by using modified fiber protein (Wu and Tikoo, 2004).
Availability of pIX-mediated targeting will help not only in
developing improved BAdV-3-based vectors for human
vaccination, but also for developing improved BAdV-3
vectors for bovine vaccination.Materials and methods
Cells and virus
MDBK and VIDO R2 (HAdV-5 E1-transformed fetal
bovine retina cells; Reddy et al., 1999b) cells were grown
in Eagle’s minimum essential medium (MEM) with 5% fetal
bovine serum (FBS). The WBR-1 strain of BAdV-3 was
propagated in MDBK cells in Eagle’s MEM containing 2%
FBS (Reddy et al., 1999a).
Antibodies and proteins
Rabbit anti-EYFP sera were purchased from Clontech.
Rabbit antisera produced against the BAdV-3 pIX peptide[M1 (61EGARRPEDQ TPYMILVEDSL80) have been de-
scribed (Reddy et al., 1999a). To raise antisera against
different regions of pIX, three synthetic peptides represent-
ing the N-terminus [N1 (13ARLPKWSQSVQDKTGSNM
L32)] and C-terminus [C1 (80LGGLKRRMDLLEENQ
QLLA99) and C2 (90LEESNQQLLATINRLRTGLAA110)]
were synthesized. Rabbits were first injected with 0.5 mg
peptide, conjugated to keyhole limpet hemocyanin in
Freund’s complete adjuvant, and subsequent two injections
were given using 0.2 mg of peptide conjugated to egg white
ovalbumin in Freund’s incomplete adjuvant at 4 weeks
interval.
The construction, expression, and purification of BAdV-
3 fiber knob protein will be described elsewhere (Wu and
Tikoo, manuscript in preparation). Briefly, the knob do-
main of BAdV-3 was expressed in baculovirus expression
system using pAcSG2 vector (Pharmingen International)
and purified as described by the manufacturer. The con-
centration of the purified knob was determined by the
Bradford protein assay (Bio-Rad) using bovine serum
albumin as a standard.
Construction of recombinant plasmids
A 12-kb NotI fragment (containing vector backbone and
nucleotide 1–10051 of BAdV-3) isolated from plasmid
pFBAV 3 (Fig. 3) was religated, creating plasmid pBAVN
(Fig. 3). A 8-kb AgeI fragment isolated from plasmid
pBAVN was religated to create plasmid pBAVNdA (Fig.
1). A 731-bp AgeI–NotI fragment [containing the gene for
enhanced yellow-green fluorescent protein (EYFP)] isolated
from plasmid pEYFP-NI (Clontech) was blunt end repaired
with Klenow and ligated to HpaI-digested pBAVNdA (Fig.
3) creating plasmid pBNdAYFP. To incorporate the RGD
peptide coding sequence into the 3V end of pIX, two over-
lapping synthetic oligonucleotides (sense oligo: 5V-GGAT-
CAGGATCAGGTTCAGGGAGTGGCTCTGCCTGC-
GACTGTCGCGGCGATTGTTTTTGCGGTTAAGTT-3V;
antisense oligo: 5V-AACTTAACCGCAAAAACAATCGCC-
GCGACAGTCGCAGGCAGAGC CACTCCCTGAACCT-
GATCCTGATCC-3V) were used to make the DNA sequence
containing the RGD motif and a short spacer encoding five
GS repeats (Wickham et al., 1997). The oligonucleotides
were annealed to form a DNA duplex and ligated to HpaI-
digested plasmid pBAVNdA (Fig. 3), creating plasmid
pBNdARGD. To extend the homologous sequence for
recombination, a 4382-bp AgeI fragment (nt 4441–8823)
of the BAdV-3 genome was ligated to AgeI-digested plas-
mid pBNdAYFP or pBNdARGD, creating plasmid pBAV-
NotYFP and pBAVNotRGD, respectively.
The recombinant BAdV-3 genomes containing pIX fused
to RGD (pFBAV950) or EYFP (pFBAV951) were generated
by homologous DNA recombination in E. coli BJ5183
(Chartier et al., 1996) between BsaBI–PmeI-digested
pFBAV3 (Fig. 3) and a 10.7-kb PacI–NotI fragment of
pBAVNotYFP or between BsaBI–PmeI-digested pFBAV3
A. Zakhartchouk et al. / Virolo(Fig. 3) and a-10 kb PacI–NotI fragment of pBAVNotRGD,
respectively.
Construction of the recombinant BAdV-3
Monolayers of VIDO-R2 cells (5  105 cells) in 60-mm
dish were transfected with 8 Ag of PacI-digested pFBAV950,
pFBAV951, or pFBAV3 by a Lipofectin method. The cyto-
pathic effects appeared 14 days after transfection. The cells
showing 50% cytopathic effects were collected, freeze–
thawed two times, and the recombinant virus was plaque
purified and propagated on MDBK cells. The insertion of
foreign sequences into the viral genome was analyzed by
PCR using viral DNA as a template. The primers used for
analysis were P91 [5V-CTAATCGATACATGTACAC TG-3V]
(3057 bp of BAV-3 genome) and P92 [5V-CCAACCG-
GTTGTGGAAAATC-3V] (4450 bp of BAV-3 genome).
Western blotting
For Western blot, proteins from CsCl-purified virions (5
Ag) were separated by 12% sodium-dodecyl sulphate (SDS)
polyacrylamide gel electrophoresis (PAGE) and transferred
to nitrocellulose membranes. Nonspecific binding sites on
the membranes were blocked with 1% BSA fraction V. The
membranes were probed with rabbit polyclonal anti-sera
against pIX of BAdV-3. The membranes were washed and
exposed to goat anti-rabbit IgG conjugated to alkaline
phosphatase. The blot was developed using alkaline phos-
phatase color development kit (Bio-Rad).
Immunogold electron microscopy
For immunogold electron microscopy, CsCl-purified viri-
ons were adsorbed to nickel grids. After adsorption, the grids
were incubated for 1 h with appropriately diluted protein-
specific sera. After several washing steps, the grids were
incubated with gold-tagged protein A for 1 h at room
temperature. Finally, the grids were stained with 2% phos-
photungstic acid and examined by transmission electron
microscopy.
Real time PCR
Total DNA was extracted from virus-infected A549 or
HeLa cells using QIAGEN DNAeasy Tissue Kit. Aliquot of
70 ng of total DNA was used in the Real Time PCR
analysis with Platinum qPCR supermix (Invitrogen). The
primers were from the BAdV-3 hexon gene sequence: RTP-
1: 5V-TACAGTAATGTGGCGTTGTA-3V and RTP-2: 5V-
CGTATCAATAAGGCCGCTAA-3V. The 5V end-labeled
FAM and 3V-labeled TAMRA probe were used in the PCR
reaction. The sequence of the probe was CCGCCTAAC-
CACGAACACCTACG. Dilutions of pFBAV3 DNA were
used for absolute quantification of viral genomes in the DNA
sample.Virus-binding assay
Monolayers of A549 cells in 12-well plates were incubat-
ed with purified BAdV-3 fiber knob protein (70 Ag/ml) or
MEM for 10 min. Wild-type BAdV-3 or BAV950 was then
added at a multiplicity of infection of 10 for 30 min at room
temperature. Alternatively, monolayers of A549 cells in 12-
well plates were incubated with RGD containing peptide (500
Ag/ml) or MEM for 10 min at 4 jC. Wild-type BAdV-3 or
BAV950 was then added at a multiplicity of infection of 10
for 30 min at 4 jC. The viruses were aspirated and the cells
were overlaid with MEM containing 5% FBS and 0.7%
agarose. After 3 days of incubation at 37 jC, the agarose
overlay was removed, the cells were fixed with 100%
methanol. Finally, the cells were stained with anti-DBP and
infectious units of BAdV-3 were counted as described (Zhou
et al., 2001). Each bar represents the cumulative meanF SD
of triplicate determinations.
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